Abstract
Objectives
This study aimed to assess the cost-effectiveness of photobiomodulation therapy (PBMT) in association with a Preventive Oral Care Program (POCP) compared with POCP alone in the treatment of radiotherapy (RT)-induced oral mucositis (OM).
Methods
The cost-effectiveness was evaluated from the health provider perspective and conducted alongside a randomized, double-blind clinical trial. Participants were randomly assigned to either PBMT (n = 25) or control (n = 23) group. The PBMT group participants received PBMT associated with POCP. In the control group, patients were submitted to POCP alone. Costs were identified, quantified, and valued through observation and consultation of the hospital’s financial sector database and estimated in Brazilian real and converted to international dollars using the purchasing power parity exchange rate. The incremental cost-effectiveness ratio (ICER) was estimated by considering the prevention of severe OM, interruption of RT, and oral health-related quality of life (OHRQoL) scores, measured by the OHIP-14 and patient-reported OM symptoms scale (PROMS).
Results
The incremental cost of PBMT was $857.35, and the cost per session was $25.69. The ICER was $ 2867.39 to avoid one case of severe OM and $ 2756.75 to prevent one interruption in RT due to OM. ICER to reduce 1 point in OHIP-14 and PROMS scores were $170.79 and $31.75, respectively.
Conclusion
PBMT is more cost-effective than POCP alone in preventing severe OM, worsening of the OHRQoL, and RT interruptions. PBMT is a promising therapy, especially to avoid interruptions in oncological treatment.
Trial registration
ReBEC-RBR-5h4y4n
![](http://media.springernature.com/m312/springer-static/image/art%3A10.1007%2Fs00520-020-05607-6/MediaObjects/520_2020_5607_Fig1_HTML.png)
![](http://media.springernature.com/m312/springer-static/image/art%3A10.1007%2Fs00520-020-05607-6/MediaObjects/520_2020_5607_Fig2_HTML.png)
Similar content being viewed by others
References
Barasch A, Peterson DE (2003) Risk factors for ulcerative oral mucositis in cancer patients: unanswered questions. Oral Oncol 39(2):91–100
Khouri VY, Stracieri AB, Rodrigues MC, Moraes DA, Pieroni F, Simões BP et al (2009) Use of therapeutic laser for prevention and treatment of oral mucositis. Braz Dent J 20(3):215–220
Pico JL, Avila-Garavito A, Naccache P (1998) Mucositis: its occurrence, consequences, and treatment in the oncology setting. Oncologist 3(6):446–451
Sonis ST, Elting LS, Keefe D, Peterson DE, Schubert M, Hauer-Jensen M et al (2004) Perspectives on cancer therapy-induced mucosal injury: pathogenesis, measurement, epidemiology, and consequences for patients. Cancer 100(9Suppl):1995–2025
Sonis ST (2011) Oral mucositis. Anti-Cancer Drugs 22(7):607–612
Elting LS, Cooksley CD, Chambers MS, Garden AS (2007) Risk, outcomes, and costs of radiation-induced oral mucositis among patients with head-and-neck malignancies. Int J Radiat Oncol Biol Phys 68(4):1110–1120
Bese NS, Hendry J, Jeremic B (2007) Effects of prolongation of overall treatment time due to unplanned interruptions during radiotherapy of different tumor sites and practical methods for compensation. Int J Radiat Oncol Biol Phys 68(3):654–661
Russo G, Haddad R, Posner M, Machtay M (2008) Radiation treatment breaks and ulcerative mucositis in head and neck cancer. Oncologist. 13(8):886–998
Nonzee NJ, Dandade NA, Patel U, Markossian T, Agulnik M, Argiris Aet al. (2008) Evaluating the supportive care costs of severe radiochemotherapy-induced mucositis and pharyngitis: results from a Northwestern University costs of cancer program pilot study with head and neck and nonsmall cell lung cancer patients who received care at a county hospital, a Veterans Administration hospital, or a comprehensive cancer care center. Cancer. 113(6):1446–1452
Bezinelli LM, de Paula EF, da Graça Lopes RM, Biazevic MG, de Paula EC, Correa L et al (2014) Cost-effectiveness of the introduction of specialized oral care with laser therapy in hematopoietic stem cell transplantation. Hematol Oncol 32(1):31–39
Oton-Leite AF, Elias LS, Morais MO, Pinezi JC, Leles CR, Silva MA et al (2013) Effect of low-level laser therapy in the reduction of oral complications in patients with cancer of the head and neck submitted to radiotherapy. Spec Care Dentist 33(6):294–300
Oton-Leite AF, Corrêa de Castro AC, Morais MO, Pinezi JC, Leles CR, Mendonça EF (2012) Effect of intraoral low-level laser therapy on quality of life of patients with head and neck cancer undergoing radiotherapy. Head Neck 34(3):398–404
Berger K (2018) Burden of oral mucositis: a systematic review and implications for future research. Oncol Res Treat 41(6):399–405
Antunes HS, Schluckebier LF, Herchenhorn D, Small IA, Araújo CM, Viégas CM et al (2016) Cost-effectiveness of low-level laser therapy (LLLT) in head and neck cancer patients receiving concurrent chemoradiation. Oral Oncol 52:85–90
Zadik Y (2019) Photobiomodulation for the palliation of oral mucositis in cancer patients: the future is here. Future Oncol 15(32):3647
Martins AFL, Nogueira TE, Morais MO, Oton-Leite AF, Valadares MC, Batista AC, Freitas NMA, Leles CR, Mendonça EF (2019) Effect of photobiomodulation on the severity of oral mucositis and molecular changes in head and neck cancer patients undergoing radiotherapy: a study protocol for a cost-effectiveness randomized clinical trial. Trials. 20(1):97
Oberoi S, Zamperlini-Netto G, Beyene J, Treister NS, Sung L (2014) Effect of prophylactic low-level laser therapy on oral mucositis: a systematic review and meta-analysis. PLoS One 9(9):2107418
Morais MO, Martins AFL, Jesus APG, Sousa-Neto SS, Costa AWF, Pereira CH et al (2020) A prospective study on oral adverse effects in head and neck cancer patients submitted to a preventive oral care protocol. Support Care Cancer:2020. https://doi.org/10.1007/s00520-019-05283-1
Parulekar W, Mackenzie R, Bjarnason G, Jordan RC (1998) Scoring oral mucositis. Oral Oncol 34(3):63–71
National Cancer Institute (NCI), National Cancer Health (NIH), Common Toxicity Criteria (CTCAE) (2017) Version 5.0. https://ctep.cancer.gov. Accessed 25 Jan 2019
Pires CP, Ferraz MB, de Abreu MH (2006) Translation into Brazilian Portoguese, cultural adaptation and validation of the Oral Health Impact Profile (OHIP-49). Braz Oral Res 20(3):263–268
Oliveira BH, Nadanovsky P (2005) Psychometric properties of the Brazilian version of the Oral Health Impact Profile-short form. Community Dent Oral Epidemiol 33(4):307–314
Bezinelli LM, Eduardo FP, Neves VD, Correa L, Lopes RM, Michel-Crosato E et al (2016) Quality of life related to oral mucositis of patients undergoing haematopoietic stem cell transplantation and receiving specialised oral care with low-level laser therapy: a prospective observational study. Eur J Cancer Care 25(4):668–674
Turner HC, Lauer JA, Tran BX, Teerawattananon Y, Jit M (2019) Adjusting for inflation and currency changes within health economic studies. Value Health 22(9):1026–1032
OECD (2020) Exchange rates (indicator). doi: https://doi.org/10.1787/037ed317-en (Accessed on 02 February 2020)
Moher D, Hopewell S, Schulz KF, Montori V, Gøtzsche PC, Devereaux PJ, Elbourne D, Egger M, Altman DG, Consolidated Standards of Reporting Trials Group (2010) CONSORT 2010 explanation and elaboration: updated guidelines for reporting parallel group randomised trials. J Clin Epidemiol 63(8):e1–e37
Nooka AK, Johnson HR, Kaufman JL, Flowers CR, Langston A, Steuer C, Graiser M, Ali Z, Shah NN, Rangaraju S, Nickleach D, Gao J, Lonial S, Waller EK (2014) Pharmacoeconomic analysis of palifermin to prevent mucositis among patients undergoing autologous hematopoietic stem cell transplantation. Biol Blood Marrow Transplant 20(6):852–857
Russo G, Haddad R, Posner M, Machtay M (2008) Radiation treatment breaks and ulcerative mucositis in head and neck cancer. Oncologist. 13(8):886–898
Thomas K, Martin T, Gao A, Ahn C, Wilhelm H, Schwartz DL (2017) Interruptions of head and neck radiotherapy across insured and indigent patient populations. J Oncol Pract 13(4):e319–e328
Lazarev S, Gupta V, Ghiassi-Nejad Z, Miles B, Scarborough B, Misiukiewicz KJ et al (2017) Premature discontinuation of curative radiation therapy: insights from head and neck irradiation. Adv Radiat Oncol 23(3):62–69
Hulme C, Yu G, Browne C, O’Dwyer J, Craddock H, Brown S et al (2014) Cost-effectiveness of silicone and alginate impressions for complete dentures. J Dent 42(8):902–907
Hulme C, Robinson PG, Saloniki EC, Vinall-Collier K, Baxter PD, Douglas G, Gibson B, Godson JH, Meads D, Pavitt SH (2016) Sha** dental contract reform: a clinical and cost-effective analysis of incentive-driven commissioning for improved oral health in primary dental care. BMJ Open 6(9):e013549
Brennan DS, Spencer AJ (2006) Map** oral health related quality of life to generic health state values. BMC Health Serv Res 6:96
Riley P, Glenny AM, Worthington HV, Littlewood A, Fernandez Mauleffinch LM, Clarkson JE et al (2017) Interventions for preventing oral mucositis in patients with cancer receiving treatment: cytokines and growth factors. Cochrane Database Syst Rev 11:CD011990
Morais MO, Elias MRA, Leles CR, Pinezi JCD, Mendonça EF (2016) The effect of preventive oral care on treatment outcomes of a cohort of oral cancer patients. Support Care Cancer 24(4):1663–1670
Zadik Y, Arany PR, Fregnani ER, Bossi P, Antunes HS, Bensadoun RJ et al (2019) Systematic review of photobiomodulation for the management of oral mucositis in cancer patients and clinical practice guidelines. Support Care Cancer 27(10):3969–3983
Gautam AP, Fernandes DJ, Vidyasagar MS, Maiya AG, Guddattu V (2015) Low level laser therapy against radiation induced oral mucositis in elderly head and neck cancer patients-a randomized placebo controlled trial. J Photochem Photobiol B 144:51–56
Antunes HS, Herchenhorn D, Small IA, Araújo CMM, Viégas CMP, Cabral E, Rampini MP, Rodrigues PC, Silva TGP, Ferreira EMS, Dias FL, Ferreira CG (2013) Phase III trial of low-level laser therapy to prevent oral mucositis in head and neck cancer patients treated with concurrent chemoradiation. Radiother Oncol 109(2):297–302
Oton-Leite AF, Silva GB, Morais MO, Silva TA, Leles CR, Valadares MC et al (2015) Effect of low-level laser therapy on chemoradiotherapy-induced oral mucositis and salivary inflammatory mediators in head and neck cancer patients. Lasers Surg Med 47(4):296–305
Funding
We thank the Foundation for Research Support in the State of Goiás—FAPEG/Ministry of Health of Brazil/ Brazilian National Council for Scientific and Technological Development—CNPq (PPSUS–201710267001233), and the Brazilian National Council for Scientific and Technological Development—CNPq (307906-7) for funding this study. This funding source did not have any role during its execution, analyses, interpretation of the data, or decision to submit results.
Author information
Authors and Affiliations
Contributions
All authors contributed to the study conception and design. Material preparation, data collection, and analysis were performed by Allisson Filipe Lopes Martins, Marília Oliveira Morais, Sebastião Silvério Sousa-Neto, Angélica Ferreira Oton-Leite, and Tulio Eduardo Nogueira. The methods of the study were designed by Allisson Filipe Lopes Martins, Marize Campos Valadares, Nilcena Maya Aires Freitas, Cláudio Rodrigues Leles, and Elismauro Francisco de Mendonça. The first draft of the manuscript was written by Allisson Filipe Lopes Martins and Tulio Eduardo Nogueira. All authors commented on previous versions of the manuscript. All authors read and approved the final manuscript.
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest.
Ethics approval
This research was approved by the Ethics Research Committee of Universidade Federal de Goiás (Protocol 2.053.687/2017) and the Araujo Jorge Cancer Hospital (Protocol 2.131.323/2017).
Consent to participate
All participants signed an informed consent to participate of this study.
Additional information
Publisher’s note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Electronic supplementary material
Supplementary Figure 1
Decision tree-type diagram of the clinically relevant events, based on WHO scale. (PNG 1267 kb)
Supplementary Table 1
(DOCX 13 kb)
Supplementary Table 2
(DOCX 13 kb)
ESM 1
(PDF 246 kb)
ESM 2
(PDF 577 kb)
ESM 3
(PDF 150 kb)
Rights and permissions
About this article
Cite this article
Lopes Martins, A.F., Nogueira, T.E., Morais, M.O. et al. Cost-effectiveness randomized clinical trial on the effect of photobiomodulation therapy for prevention of radiotherapy-induced severe oral mucositis in a Brazilian cancer hospital setting. Support Care Cancer 29, 1245–1256 (2021). https://doi.org/10.1007/s00520-020-05607-6
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00520-020-05607-6